Janssen Biotech Inc.

08/07/2024 | Press release | Distributed by Public on 08/07/2024 15:24

Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of[...]